Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-17 Sale |
2025-03-19 4:21 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
26,756 | $152.51 | $4,080,663 | 338,645 (Direct) |
View |
| 2025-03-17 Purchase |
2025-03-18 3:58 pm |
REPLIGEN CORP | RGEN | Pax Margaret Director |
250 | $150.69 | $37,673 | 1,043 (Direct) |
View |
| 2024-11-21 Sale |
2024-11-22 4:52 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
24,246 | $139.67 | $3,386,439 | 139,840 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 11:35 am |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
22,191 | $145.37 | $3,225,927 | 164,086 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-04 7:25 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
13,146 | $0 | $0 | 158,559 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-05 9:56 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
7,148 | $159.35 | $1,139,016 | 12,288 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-01 8:47 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,465 | $165.67 | $739,717 | 19,261 (Direct) |
View |
| 2024-06-14 Purchase |
2024-06-14 6:07 pm |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
1,615 | $124.94 | $201,776 | 4,624 (Indirect Direct) |
View |
| 2024-06-14 Purchase |
2024-06-14 5:42 pm |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,200 | $125.45 | $150,540 | 4,668 (Direct) |
View |
| 2024-06-14 Purchase |
2024-06-14 5:41 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
2,000 | $124.08 | $248,160 | 165,177 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 5:14 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,072 | $168.26 | $3,377,283 | 163,177 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Tax Withholding |
2025-04-02 10:33 am |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
454 | $128.5 | 23,711 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-20 1:51 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
381 | $0 | 24,165 (Direct) |
View |
| 2025-03-13 Tax Withholding |
2025-03-20 1:51 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
175 | $142.44 | 24,165 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 4:21 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
5,000 | $33.87 | 338,645 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 4:21 pm |
N/A 2028-03-01 |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
26,756 | $0 | 338,645 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 4:21 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
21,756 | $59.52 | 338,645 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 1:42 pm |
N/A 2035-03-03 |
REPLIGEN CORP | RGEN | Garland Jason K CFO |
12,491 | $0 | 19,851 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 1:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
386 | $155.38 | 20,604 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 1:41 pm |
N/A 2035-03-03 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
9,368 | $0 | 20,604 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 1:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
10,142 | $155.38 | 136,301 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 1:29 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
1,239 | $155.38 | 30,015 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 1:29 pm |
N/A 2035-03-03 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
12,491 | $0 | 30,015 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 1:18 pm |
N/A 2035-03-03 |
REPLIGEN CORP | RGEN | Loeillot Olivier Chief Executive Officer |
28,107 | $0 | 60,320 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-02-28 4:36 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Garland Jason K CFO |
316 | $156.54 | 7,360 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-02-28 4:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Loeillot Olivier Chief Executive Officer |
343 | $156.54 | 32,213 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-02-28 4:29 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
1,285 | $156.54 | 18,763 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-02-28 4:28 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
391 | $156.54 | 11,622 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-02-28 4:26 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
2,825 | $156.54 | 146,443 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-25 10:28 am |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
275 | $164.74 | 12,013 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-25 10:27 am |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
543 | $164.74 | 20,048 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-25 10:18 am |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
2,380 | $164.74 | 149,268 (Direct) |
View |
| 2024-12-05 Exercise |
2024-12-05 8:26 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
11,808 | $33.87 | 160,504 (Direct) |
View |
| 2024-12-05 Exercise |
2024-12-05 8:26 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
11,808 | $0 | 160,504 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-22 4:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
24,246 | $33.87 | 139,840 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-22 4:52 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
24,246 | $0 | 139,840 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-21 2:10 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Garland Jason K CFO |
367 | $123.41 | 7,676 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-21 1:32 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Loeillot Olivier Chief Executive Officer |
861 | $123.41 | 32,556 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-20 2:29 pm |
N/A 2025-09-14 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
19,000 | $0 | 32,283 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-20 2:29 pm |
N/A N/A |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
19,000 | $36.29 | 32,283 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 11:35 am |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
10,000 | $33.87 | 164,086 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 11:35 am |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Director |
10,000 | $0 | 164,086 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-04 8:41 pm |
N/A 2034-09-03 |
REPLIGEN CORP | RGEN | Loeillot Olivier Chief Executive Officer |
33,909 | $0 | 49,695 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-05 9:56 pm |
N/A 2030-02-27 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
175 | $0 | 12,288 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-05 9:56 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
175 | $86.1 | 12,288 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-01 5:04 pm |
N/A 2025-09-14 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
5,000 | $0 | 13,283 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-01 5:04 pm |
N/A N/A |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
5,000 | $36.29 | 13,283 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 5:33 pm |
N/A 2029-05-15 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,953 | $0 | 88,170 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 5:33 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,953 | $67.71 | 88,170 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 7:51 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
2,077 | $0 | 4,385 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 7:32 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | Mhatre Rohin Director |
2,077 | $0 | 4,422 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 7:30 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | Pax Margaret Director |
2,077 | $0 | 2,169 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 7:27 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | Konstantinov Konstantin Director |
2,077 | $0 | 3,297 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 6:53 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
2,077 | $0 | 4,869 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 6:50 pm |
2025-05-16 2034-05-16 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
2,077 | $0 | 4,844 (Direct) |
View |